AIM movers: Frasers Group approach to Revolution Beauty and Cordel disappoints

44

Argentex Group (LON: AGFX) has received a non-binding proposal from Lavide Holding NV for a £2.5m investment in shares and the provision of a £15m credit facility. This has been rejected because it is not a full offer for the company. The share price rebounded 29.6% to 3.175p.

EnergyPathways (LON: EPP) has engaged Zeith Energy as its well engineering partner for the Marram Energy Storage Hub (MESH) integrated energy storage project in the Irish Sea. The share price increased 13.1% to 5.6p.

Empire Metals (LON: EEE) says the latest results from the product development test programme at the Pitfield project in Western Australia. The TiO2 is high purity and assays at 99.25%. This is suitable for titanium sponge or pigment production. The bulk sampling programme continues. The share price rose 14.5% to 16.15p.

Cosmetics supplier Revolution Beauty (LON: REVB) has confirmed that there are a number of parties interested in making an offer for the company and they include fully listed Frasers Group (LON: FRG). Boohoo Group (LON: BOO) is the largest shareholder with 29%. The share price improved 9.56% to 7.91p.

Audio visual services provider MediaZest (LON: MDZ) has appointed Keith Edelman as chairman. He has previously been chief executive of Storehouse. The company believes it can return to profit in 2025. The share price

Galantas Gold Corporation (LON: GAL) has entered into a binding term sheet with Ocean Partners UK to joint venture the Omagh gold project in Northern Ireland. Ocean Partners will swap £10.3m of loans for 80% stakes in Flintridge Resources and Omagh Minerals. Galantas Gold will own the other 20%. Ocean Partners can convert the remaining £738,000 of remaining debt into a 0.001% interest in Flintridge after mining has restarted. Ocean Partners will invest an additional £2.2m in the Omagh project and has the option to invest a further £3.7m. The deal means that Galantas Gold will be reclassified as a cash shell. There is an option to convert the 20% stake in Flintridge into a 3% net smelter royalty.  Melquart, which own 24.5% of Galantas Gold will convert its debt and interest of £781,000 into 17.6 million shares at 4.4p each. That will increase its stake to 35.4%. The share price is 9.09% higher at 6p.

Video games developer Frontier Developments (LON: FDEV) is launching Jurassic World Evolution 3 on 21 October. The game allows players to nurture dinosaurs. The latest film Jurassic World Rebirth is set to be released on 2 July. The share price moved up 6.3% to 265.75p.

FALLERS

Transport analytics services provider Cordel (LON: CRDL) says economic conditions, particularly in the US, have led to delays in revenues. This is despite continued contract wins. Cavendish has cut its forecast 2024-25 revenues from £6.2m to £4.8m, although the loss will be similar at around £400,000. Cordel is no longer expected to make a profit in 2025-26. There will still be net cash. The share price lost some of last week’s gains and fell 12.3% to 7.125p.

Catenai (LON: CTAI) investee company Alludium has been accepted into two start up programmes with AWS Activate and Atlassian.  The share price declined 6.33% to 0.37p.

Mosman Oil & Gas (LON: MSMN) says moving the drilling rig to the Vecta project has been delayed by rainfall in Colorado. The share price slipped 6.1% to 0.0385p.

FTSE 100 flat as US and China meet for trade talks

The FTSE 100 got off to a benign start to the week as investors awaited news from trade talks between the US and China in London.

London’s leading index was down 0.1% at the time of writing.

“There’s caution at the start of the week, as trade talks get underway in London to try to stem a bigger trade war erupting between the world’s largest two economies,” said Susannah Streeter, head of money and markets, Hargreaves Lansdown.

“The UK has a new role as an intermediary between a belligerent US and an unyielding China. While Xi Jinping’s administration has shown determination not to bow down to Trump’s tariff intimidation, having already been forging deeper trading relationships with other nations, there are hopes that both sides will want to agree on a deal. China’s flexed its muscles by restricting the export of rare earth minerals, vital for so many industries, including car production.”

Although markets are becoming accustomed to the unpredictability of Trump’s approach to trade negotiations, the talks in London still have the power to move markets, and traders were holding off big bets on Monday.

China-focused FTSE 100 stocks were marginally bid in the hope of progress between China and US. Glencore rose 0.8% and Prudential rose 0.9%.

However, the optimism wasn’t shared among all mining stocks, with Antofagasta and Rio Tinto trading slightly negatively.

M&G was the FTSE 100’s top riser after the asset manager received a price target upgrade from UBS. Analysts now have a price target of 275p. M&G shares were 2% higher at 248p.

WPP was the top faller on the news that CEO Mark Read will step down at the end of the year, after a period of poor performance for the shares.

“The fact WPP’s share price had more than halved over the past three years meant Mark Read’s days were always numbered as CEO,” AJ Bell investment director Russ Mould.

“Shareholders can be patient, but there reaches a point where they can wait no longer and something has to change in order to revive the share price.”

Alphawave agrees $2.4 billion takeover by Qualcomm

American semiconductor giant Qualcomm has reached an agreement to acquire British chip designer Alphawave IP Group for approximately $2.4 billion in a deal.

The deal will see yet another UK tech stock leave London’s markets.

The cash offer of 183p represents a premium of 96% above the closing price of 94 pence 31st March 2025 – the closing price the may before an initial offer was made. There are a number of offers on the table for investors; a cash offer and two involving Qualcomm shares.

Alphawave shares were 22% higher at 183p at the time of writing.

“Qualcomm’s acquisition of Alphawave represents a significant milestone for us and an opportunity for our business to join forces with a respected industry leader and drive value to our customers,” said  Tony Pialis, President and Chief Executive Officer of Alphawave.

“By combining our resources and expertise, we will be well-positioned to expand our product offerings, reach a broader customer base, and enhance our technological capabilities. Together, we will unlock new opportunities for growth, drive innovation, and create a leading player in AI compute and connectivity solutions. For our shareholders, the Alphawave Board is pleased that Qualcomm’s offer provides an opportunity to realise compelling value for their shares.”

While the deal provides a substantial uplift on Alphawave’s share at the beginning of the year, it is well below the group’s 2021 highs when shares traded above 450p.

Alphawave’s revenue has nearly tripled over this period.

Qualcomm’s takeover of the group is the latest demonstration of London’s equity markets’ inability to price technology shares properly.

Director deals: Springfield Properties chairman buying back shares

In the first week in June, Springfield Properties (LON: SPR) chairman Sandy Adam bought 200,000 shares at 94.5p each in the housebuilder. That followed a purchase of 25,000 shares at 95p each late in May. He owns 23.3% of the company.
Last summer, Sandy Adam transferred 10 million shares to his children, and he also sold 225,000 shares at an average price of 93.55p each.
Business
Springfield Properties is a housebuilder that is focused on Scotland. It has local knowledge and connections. Even after aa recent land disposal there are still around 8,000 plots in the landbank. The core business is...

Aquis weekly movers: Valereum deal with Fideum

File Forge Technology has completed the reverse takeover of personal care products contract manufacturer Amirose London Holdings (LON: ALH) and changed its name to that of the new business. Alfred Henry Corporate Finance is corporate adviser. The shares were suspended at 0.07p and 24 have been consolidated into one new shares, so the equivalent price is 1.68p. The share price has increased 93.5% to 3.25p.

India-based Sachin Srinivas Sawrikar, designated partner of Artha Bharat Investment Managers, has taken a 4.25% stake in Invinity Energy Systems (LON: IES). The share price improved 1.59% to 16p.

FALLERS

S-Ventures (LON: SVEN) shares returned from suspension following the sale of the trading businesses to AIM-quoted Tooru (LON: TOO) in return for 466.7 million shares. The company has tax losses of £2.6m. The share price slumped 87.1% to 0.225p.

Recycling company Majestic Corporation (LON: MCJ) has raised £171,000 at 80p/share. Andrew Male has stepped down as a director. The 2024 accounts should be published by the end of June. The share price declined 32.4% to 125p.

Valereum (LON: VLRM) has signed a binding memorandum of understanding with Fideum, which will help to Valereum to implement SaaS services, and they will cross-sell to existing clients. The two companies will set up a joint pilot project in Turkey. Valereum has invested $2.5m in Blubird Global Inc, which operates a platform that administers more than $55bn of token assets. Valereum will have access to Blubird tools, and it will promote Valereum to selected customers. There is also potential for Valereum to offer the Blubird suite under its brand. There was £500,000 raised at 4p/share. Fortified Securities has been appointed company broker. The share price fell 14.1% to 4.25p.

Time To ACT (LON: TTA) says that the Offshore Renewable Energy Catapult innovation centre has completed a validation of GreenSpur’s axial flux generator platform. This shows a reduction in cost of energy and weight savings. The technology is suitable for industrial scale manufacturing. Jeremy Earnshaw has joined the board, and Andrew Hall has stepped down. The share price decreased 11.8% to 37.5p.

Helium Ventures (LON: HEV) has published notice of a general meeting to gain shareholder approval for investing in Bitcoin, issuing additional shares and changing the company name to VaultZ Capital. The share price dipped 11.8% to 3.75p.

Wishbone Gold (LON: WSBN) confirmed that key drill holes at the Red Setter gold project will be deepened and appear to be in good order. There will be minor work for access. The share price declined 8.82% to 0.155p.

Oscillate (LON: MUSH) says the initial exploration of the Duekoue molybdenum copper gold project in Ivory Coast is progressing. Drilling is planned by the joint venture before the end of the year. The share price slipped 6.25% to 0.375p.

Ananda Developments (LON: ANA) says lead development product MRX1, has achieved 24 months of stability data. The company’s Phase 1 pharmacokinetic (PK) study has been published on clinicaltrials.gov. This is required prior to clinical trials. The share price declined 6.15% to 0.305p.

Fenikso Ltd (LON: FNK) received a $553,700 partial repayment of its loan to Lekoil and Gas Investments. This will go towards repaying the loan from Savannah Energy Investments. The share price fell 3.33% to 1.45p.

Unsurprisingly since the strong share price performance following flotation, the Smarter Web Company (LON: SWC) share price has dipped 1.82% to 81p. The company raised a further £13.4m at 81p/share. Andrew Webley bought 10,000 shares at 81p each, taking his stake to 14.6%. The Bitcoin purchasing continues and the total has increased to 122.76 Bitcoins at an average purchase price of £78,290 each.

Coinsilium (LON: COIN) has raised £750,000 from a retail offer at 6p/share. Subsidiary Forza Gibraltar has bought 3.6378 Bitcoins at an average price of £76,969.60 each. This takes the Bitcoin holding to 13.6399 Bitcoin. The share price edged down 0.7% to 6.85p.

AIM weekly movers: 4Global decides to ditch AIM

0

Cannabis-based medicines developer Celadon Pharmaceuticals (LON: CEL) is continuing talks with a new finance provider that has indicated that it is in the process of making funds available. There is currently limited working capital. If the funds are not received in the next week, then the company will be placed in administration. If they are, Celadon intends to leave AIM. Even so, the share price doubled to 10p.

Shuka Minerals (LON: SKA) has received interim authorisation from the authorities in Zambia for the acquisition of 100% of Leopard Exploration and Mining, which owns the Kabwe zinc mine. The approval has to be ratified by the full board of commissioners. The share price increased 57.1% to 5.5p.

Tungsten West (LON: TUN) says that the Hemerdon tungsten and tin mine in Devon has been selected by the EC as a strategic project. The EU is trying to secure supplies of critical materials, and this provides access to EU funding. The share price improved 48.9% to 6.7p.

Predictive genetics company GENinCode (LON: GENI) has started to generate revenues in the US but the major growth came from the UK and the Europe. In 2024, revenues were one-quarter higher at £2.7m. Overheads were reduced. Following a de Novo submission for CARDIO inCode, the FDA has requested that deficiencies in relation to clinical validation be addressed, but management believes that US approval can be achieved. The timing is uncertain. Disruptions to staffing at the FDA under the new US government could delay matters. However, the current forecasts assume most of the growth in revenues to £4.3m in 2025 will continue to come from the UK and Europe. There is enough cash to take the company into the first quarter of 2026 and the company could be approaching breakeven by then. The share price rebounded 38.7% to 2.15p.

FALLERS

Sports and fitness data analyser 4Global (LON: 4GBL) plans to leave AIM after less than four years on the junior market. It was unable to raise additional funding to finance its growth in North America and it believes it will be easier to raise cash if it is private. Leaving AIM would save £500,000 each year. There has been limited trading in the shares and the cancellation, which is dependent on shareholder approval, is expected to be on 7 July. The share price slumped 47.7% to 11.5p. The December 2021 placing price was 91p.

Trellus Health (LON: TRLS) reported an increased loss of $7.8m on minimal revenues in 2024. Net cash was $4.3m at the end of 2024 and this fell to $2.5m at the end of April 2025. More finance is required by October. The pilot with Johnson & Johnson covering Trellus Elevate for the support of individuals with IBD is ramping up. This should help to boost revenues. The clinical trials sector is another focus for developing income. So far this year, $340,000 in revenues have been generated. The share price dipped 47.2% to 0.95p.

US-based Neptune Retail Solutions has informed digital loyalty and promotions platform operator Eagle Eye (LON: EYE) that a US grocer is terminating its contract at the beginning of August. This is a high margin contract and is the only one obtained via Neptune Retail Solutions. This will not hit the figures for the year to June 2025, but there will be sharp falls in forecast revenues and profit over the next two years. The 2025-26 revenues estimate has been reduced from £52.5m to £43.1m and Eagle Eye will make a loss. Net cash is still expected to be more than £10m at the end of June 2026. There are potential new contracts that could improve the outlook. Canaccord Genuity has trimmed its stake from 11.9% to 10.6%. The share price decreased 42% to 204p.

AI-based services provider to smaller businesses Pri0r1ty Intelligence Group (LON: PR1) has raised £1.05m at 2.5p/share. The reverse takeover at the end of 2024 was based on a price of 13.5p. The cash will be invested in growing the business. There is also a potential all-share deal to acquire sports data management business Halfspace, which the company already has a joint venture with. That would require the issue of 30.8 million shares. The share price fell 37.1% to 2.2p.

AIM movers: Bango moves into profit and SDI acquisition

7

Machine learning company Insig AI (LON: INSG) chief executive Richard Bernstein has bought another 125,000 shares at 28.5p each, taking his stake to 20.1%. The share price is one-eighth higher at 36p.

Ironveld (LON: IRON) has completed its first blast at the opencast pit on the Altona farm. This is expected to have exposed around 3,000 tons of unweathered magnetite ore. Waste rock will be removed and then there will be blasting of the exposed magnetite and delivery of ore delivery to the dense media separation plant. Targeted production is 20,000 tons of unweathered magnetite each month. The share price rose 7.84% to 0.055p.

Scientific instruments producer SDI Group (LON: SDI) is acquiring Severn Thermal Solutions for £4.75m. The business supplies high temperature furnace systems and environmental chambers for material processing and testing. This del should be immediately earnings enhancing. Cavendish upgraded its 2025-26 earnings by 4% to 7.1p/share. The share price increased 9.86% to 78p.

Camellia (LON: CAM) launched a tender offer for up to 350,000 shares at £54 each. It says 215,084 shares were tendered in the offer. The share price improved 4.33% to £54.25.

FALLERS

Non-executive directors Brian Howlett and Juliet Thompson are leaving the Angle (LON: AGL) board. The cancer diagnostics technology and services developer is reviewing the structure of the board. The share price slipped 15.6% to 6.75p.

Cancer therapeutics developer ValiRx (LON: VAL) had cash of £1.56m at the end of 2024. There was a £1.58m cash outflow from operating activities during the year. There have been £200,000 of savings of staffing costs since the year end. The accounts were prepared on a going concern basis and is reliant on further fundraisings. Stephen Wolstenhulme increased his shareholding from 5.84% to 6.17%. The share price declined 10% to 0.45p.

Direct carrier billing and digital content services provider Bango (LON: BGO) moved into profit in 2024. Revenues grew from $46.1m to $53.4m, while a loss of $5.7m was turned into a pre-tax profit of $4.8m. The Digital Vending Machine (DVM) technology, which enables bundling of subscription services, added nine licence customers in 2024 and a further five, so far this year. Annualised recurring revenues grew 59% to $14m, reflecting the DVM growth. The payments business has been hit with high costs of sales routes and this year’s trading is currently below expectations. Net debt was $1.8m at the end of 2024. Working capital movements boosted the cash inflow, but those are likely to unwind this year. New financing agreements provide the required capital for the investment in improving efficiency and growing the business. This year will be one of consolidation with a dip in pre-tax profit to $4m estimated, before the benefits of work done show through in 2026 when pre-tax profit could rebound to $8.6m. The share price dipped 6.95% to 87p.

Biotechnology company Avacta (LON: AVCT) reported a 2024 loss of £29m on continuing revenues of £110,000. Avacta had cash of £17.3m at the end of April 2025 following the sale of the diagnostics business and that cash should last until the end of the year. The share price fell 6.57% to 32p.

Africa-focused oil and gas producer Savannah Energy (LON: SAVE) reported average gross production was slightly lower at 23,100 barrels of oil equivalent/day in 2024. Total revenues were ahead of expectations at $259m and EBITDA was $181m. The audit of these figures is not yet complete. Net debt was $636.9m at the end of 2024. A new debt facility has been greed. Production improved to 23,600 barrels of oil equivalent/day in the first quarter of 2025. The share price decreased 4.23% to 6.225p.

What Disney tells us about how we draw investment conclusions 

Gabriel Sacks, Co-manager, abrdn Asia Focus plc 

Walt Disney excelled in the art of fairytales. He first demonstrated a talent for them in the early 1920s, when he was still working at the humble Laugh-O-Gram studio, rattling out the likes of Little Red Riding Hood, Jack and the Beanstalk and Puss in Boots

In the early 1930s, under the aegis of his Silly Symphony series, he produced classics such as The Ugly Duckling, Babes in the Wood and Three Little Pigs. Snow White and the Seven Dwarves, his first full-length animated feature, followed in 1937. 

Yet there was one significant area in which Disney did not deal in fairytales: business. He had a vision, and he fulfilled it. He moved on from Laugh-O-Gram, kept expanding and innovating and eventually used the profits from Snow White to establish an empire that remains a major force in film and television today. 

This is the stuff of which investors dream. Show us a fledgling company that has a truly compelling strategic plan for long-term growth – and, better still, which is able to successfully carry it out – and we are as happy as Mickey Mouse in a cheese factory. 

Unfortunately, such instances are rare. The business world is replete with compelling stories, but many of them turn out to be better suited to a golden-age Disney script than to a golden-age Disney investor relations presentation. 

As a result, separating fact from fiction is a crucial challenge. It can be especially important when weighing up the pros and cons of smaller companies, whose narratives are almost invariably centred on long-term growth, and when surveying the opportunities in emerging markets (EMs), where competition for capital can be unusually intense. 

So how does our fund, which specialises in smaller companies in Asia, go about distinguishing fact from fiction? Here are some of the tests, measures and guidelines we apply when searching for the region’s brightest investment opportunities and hidden gems. 

  • Favouring reality over hyperbole 

We first need to accept most Asian smaller companies are unlikely to have a tale as inherently eye-catching as, say, Apple’s or Microsoft’s. We also have to recognise they might not boast the storytelling skills of a mega-cap technology titan. 

This being the case, our initial attention is most likely to be grabbed by a corporate narrative that is reasonably polished, makes sense and appears grounded in reality. One that fails to “hang together” and/or is clearly couched in hyperbole tends to fall at the first hurdle. 

  • Taking a closer look 

Businesses that pass the above test must still be treated with scepticism. This might sound unkind, but it is scepticism that underpins fully informed investment decisions. Nothing should be taken for granted. 

A company’s financial statements are often the first port of call when scrutiny is applied in earnest. Quantitative research might show that the underlying data is vague or suspiciously selective and that the numbers simply do not add up. As we will see next, though, this level of analysis could be insufficiently revealing. 

  • Bringing on-the-ground expertise to bear 

Wherever in the world they may be, smaller companies are frequently under-researched. In a market such as Asia – and particularly in its EMs – many could be the subject of little or no coverage. 

This is why we argue that there is huge merit in having an on-the-ground presence. Investment teams with local knowledge should be better positioned to differentiate between businesses that offer genuine promise and businesses whose appeal turns out to be strictly illusory. 

  • Digging deeper through direct engagement 

This brings us to the value of direct engagement. In our view, this is the most powerful means of seeing beyond the surface gloss of a company’s narrative and determining whether there is an authentic prospect of long-term growth and outperformance. 

Face-to-face meetings with a business’s management allow us to dig much deeper into figures, claims and projections. Ideally, we want to hear a persuasive articulation of strengths, weaknesses and the proposed way ahead. In short: we want to find out what really makes a company tick. 

  • Seeking reassurance in the face of uncertainty 

Of course, there will be many instances when we choose to invest in a company and then encounter a situation in which the story we have bought into is challenged. Maybe the most obvious example is when growth expectations are not met. 

What matters here is how management responds. Basically, we like to see a combination of optimism and pragmatism. Is there a straightforward, sensible explanation for what has happened? Are there solid grounds for believing the situation will improve? Will guidance be adjusted accordingly? This takes us back to where we started: we are looking for clarity and rationality, not obfuscation and make-believe. 

Companies selected for illustrative purposes only to demonstrate the investment management style described herein and not as an investment recommendation or indication of future performance. 

Important information 

  • The value of investments, and the income from them, can go down as well as up and investors may get back less than the amount invested. 
  • Past performance is not a guide to future results. 
  • Emerging markets tend to be more volatile than mature markets and the value of your investment could move sharply up or down. 
  • Investment in the Company may not be appropriate for investors who plan to withdraw their money within 5 years. 
  • The Company may borrow to finance further investment (gearing). The use of gearing is likely to lead to volatility in the Net Asset Value (NAV) meaning that any movement in the value of the company’s assets will result in a magnified movement in the NAV. 
  • The Company may accumulate investment positions which represent more than normal trading volumes which may make it difficult to realise investments and may lead to volatility in the market price of the Company’s shares. 
  • The Company may charge expenses to capital which may erode the capital value of the investment. 
  • The Company invests in smaller companies which are likely to carry a higher degree of risk than larger companies. 
  • Movements in exchange rates will impact on both the level of income received and the capital value of your investment. 
  • There is no guarantee that the market price of the Company’s shares will fully reflect their underlying Net Asset Value. 
  • As with all stock exchange investments the value of the Company’s shares purchased will immediately fall by the difference between the buying and selling prices, the bid-offer spread. If trading volumes fall, the bid-offer spread can widen. 
  • The Company invests in emerging markets which tend to be more volatile than mature markets and the value of your investment could move sharply up or down. 
  • Specialist funds which invest in small markets or sectors of industry are likely to be more volatile than more diversified trusts. 
  • Yields are estimated figures and may fluctuate, there are no guarantees that future dividends will match or exceed historic dividends and certain investors may be subject to further tax on dividends. 

Other important information: 

The details contained here are for information purposes only and should not be considered as an offer, investment recommendation, or solicitation to deal in any investments or funds and does not constitute investment research, investment recommendation or investment advice in any jurisdiction. Any data contained herein which is attributed to a third party (“Third Party Data”) is the property of (a) third party supplier(s) (the “Owner”) and is licensed for use with Aberdeen. Third Party Data may not be copied or distributed. Third Party Data is provided “as is” and is not warranted to be accurate, complete or timely. To the extent permitted by applicable law, none of the Owner, Aberdeen, or any other third party (including any third party involved in providing and/or compiling Third Party Data) shall have any liability for Third Party Data or for any use made of Third Party Data. Neither the Owner nor any other third party sponsors, endorses or promotes the fund or product to which Third Party Data relates. 

The abrdn Asia Focus plc Key Information Document can be obtained here

Issued by abrdn Fund Managers Limited, registered in England and Wales (740118) at 280 Bishopsgate, London EC2M 4AG. The company is authorised and regulated by the Financial Conduct Authority in the UK. 

Find out more at aberdeeninvestments.com/aas or by registering for updates. You can also follow us on X, Facebook and LinkedIn

Rosebank makes first acquisition under “Buy, Improve, Sell” strategy

Rosebank Industries has announced its first acquisition since the vehicle listed in London last year. Rosebank has acquired Electrical Components International (ECI), a leading US electrical distribution systems company, in a deal valued at around $1.9 billion enterprise value.

The acquisition, which marks Rosebank’s first under its “Buy, Improve, Sell” strategy, is being financed through a fully underwritten institutional capital raise of approximately £1.14 billion at £3.00 per share, alongside $900 million in new debt facilities.

“The effective Melrose 2.0 has found its first target for a ‘buy, improve, sell’ strategy,” said Russ Mould, investment director at AJ Bell.

“Rosebank was launched by former Melrose directors with the aim of replicating previous success in finding businesses that were battered, bruised or had simply lost their way, and sprucing them up before flipping at a premium.”

ECI, which generates around $1.3 billion in annual revenues with an adjusted operating margin of approximately 13%, is a leader positions in wire harnesses and controls across industrial, electrification, HVAC and appliance sectors. North America accounts for roughly 80% of the company’s revenues.

Rosebank’s goal is to improve operations, aiming to boost ECI’s operating margin by five percentage points to at least 18%, which would lift adjusted EBITDA margins to at least 20%. The plan is to launch a wave of cost-saving initiatives, restructuring, and working capital optimisation.

The company also intends to continue ECI’s acquisition strategy of purchasing smaller, complementary high-margin businesses.

“This is the first step on the journey and we are very confident that we can help ECI to fully realise its potential for the benefit of its employees, customers and our shareholders,” said Simon Peckham, Rosebank CEO.

The acquisition represents approximately 9x expected 2025 adjusted EBITDA, with Rosebank targeting a doubling of its investment over three to five years.

“Rosebank is certainly not buying electrical components business ECI on the cheap,” Russ Mould said.

“It is paying nine times adjusted earnings which is fine for a company that is running smoothly, but twice as much as you might find with acquisitions of a broken business. Rosebank hopes to improve ECI’s margins, improve working capital and reduce leverage so servicing debt doesn’t consume so much of its cash flow. This sounds like fine-tuning the engine rather than chucking in a new one.”

FTSE 100 gains amid Trump and Musk fight

The FTSE 100 ticked higher on Friday as investors digested a fight between the world’s richest man and the world’s most powerful man that played out on social media overnight.

Donald Trump and Elon Musk fired shots at each other on the social media platforms they own, with Musk claiming that Donald Trump is in the Epstein files, and Trump suggesting that he will cancel billions in government contracts with Musk’s companies.

Tesla shares fell 14% overnight, and Musk said Trump should be impeached. Elon Musk also said that Donald Trump’s tariffs will push the US into recession.

“We all knew it would end like this. Two big beasts in the White House were unlikely to last long, and the bromance has turned sour. Tesla shares are the big loser from the fallout, after their nosedive yesterday, while markets patiently await the latest payroll report,” said Chris Beauchamp, Chief Market Analyst at global trading platform IG.

While the spat makes for very interesting reading for traders, it’s yet to have a major impact on UK markets. The S&P 500 closed down 0.5%, but futures are pointing to a higher open.

“The FTSE looks unlikely to move much this morning with little scheduled in the way of corporate news for investors to hang their hat on. That sentiment reflects an unremarkable 24 hours on markets across the globe,” said Derren Nathan, head of equity research, Hargreaves Lansdown.

“But world markets remain at close to all-time highs, despite the reality of higher tariffs and diminishing confidence for both businesses and consumers. So, it’s little surprise investors are taking their foot off the gas.”

There were slightly more FTSE 100 gainers than losers at the time of writing, with 58 of the 100 constituents trading higher.

SSE was the FTSE 100’s top riser with a gain of 1.5%.

Housebuilders were higher after Halifax released data showing the average UK house price fell 0.4% in the month to May. Persimmon rose 1% and Taylor Wimpey added 0.7%.